Synthesis and biological evaluation of n-butylphthalide derivatives as anti-platelet aggregation agents

Natural Product Research
Meihui ChenDingkun Lin

Abstract

New analogues of n-butylphthalide (NBP) bearing various lengths of alkyl and different substitution at the two-position of phthalide were designed and synthesised. Preliminary evaluation and prediction of ACD LogP software indicate that the derivatives display significant improvement in water solubility than NBP does. Further biological analysis showed that NBP analogues specifically inhibit platelet aggregation induced by arachidonic acid but have no effect on that induced by adenosine 5-diphosphate. Especially compounds 1 and 3 were stronger than classical anti-platelet drug, aspirin, and equal potent with NBP, respectively. These findings provide an alternative approach to the development of NBP analogues with anti-platelet aggregation activity with good water solubility for the intervention of ischemic stroke.

References

Jan 16, 2010·Pathophysiology : the Official Journal of the International Society for Pathophysiology·Prabal DebK M Hassan
Jun 21, 2011·Bioorganic & Medicinal Chemistry Letters·Yang LiYihua Zhang
Jul 26, 2012·Journal of Medicinal Chemistry·Jing WuYihua Zhang
Jul 24, 2013·International Journal of Pharmaceutics·Phuong Ha-Lien TranBeom-Jin Lee
Jan 29, 2014·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Xingxing DiaoXiaoyan Chen

❮ Previous
Next ❯

Citations

Jan 11, 2021·American Journal of Otolaryngology·Min XiongLan Yu

❮ Previous
Next ❯

Software Mentioned

ACD

Related Concepts

Related Feeds

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.